Skip to main content
Caplight Logo









Prominex, Inc.

Prominex, Inc.

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://prominex.com/

Last Round

Series B

Extension

Feb 24, 2020

Total Funding Raised

$19.2M

Company Overview

Prominex, Inc. is a biotechnology company that develops rapid, point-of-care molecular diagnostic solutions for infectious disease testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Keywords

point-of-care diagnosticsmolecular diagnosticsPOC testinginfectious disease testingmultiplexed testingrapid diagnosticsrazor-and-blade modeldiagnostic instrumentassay cartridgesmedical devicenear-patient testingmolecular amplificationlateral-flow detectionclinical diagnosticsrapid test

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prominex, Inc. Comparables

Compare Prominex, Inc. with similar companies based on industry and business-model similarity.

Prominex, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anavasi Diagnostics
85%
Aptitude Medical
80%
Visby Medical
80%

Prominex, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionFeb 24, 2020
Series BMay 31, 2019
Series A ExtensionSep 13, 2018
Series AJan 5, 2018

Key People

Founding team and executive leadership

Paul Thomas

Chief Executive Officer

Executive Team

Prominex, Inc. Investors

Notable investors and investment history

Prominex, Inc. investors
InvestorRounds
Casdin CapitalSeries B, Series A, Series B Extension, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2025

    Monthly visitors grew 269% MoM, from 325 to 1.2K.

  • Feb 4, 2025

    Grew 27% QoQ, from 11 to 14 employees.

Prominex, Inc. Filings

Explore SEC and related filing metadata, where available.

Prominex, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Prominex, Inc.'s valuation, stock price, and market status.

Is Prominex, Inc. a public or private company?

Prominex, Inc. is a private company.

What is the current stock price of Prominex, Inc.?

Prominex, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Prominex, Inc. worth (valuation)?

Valuation information for Prominex, Inc. is not publicly available.

Can I buy Prominex, Inc. stock?

Prominex, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Prominex, Inc.'s last funding round?

Prominex, Inc.'s most recent funding round was Series B Extension on February 24, 2020.

Who are the main investors in Prominex, Inc.?

Key investors in Prominex, Inc. include Casdin Capital.

Will Prominex, Inc. IPO soon?

No public IPO plans have been announced for Prominex, Inc..

How can I track Prominex, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Prominex, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range16
Year Founded2018
Last FundingFeb 24, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?